Pharma

Your Article Summary

See Latest Articles

Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 08/24/09

Chugai Pharmaceutical Co., Ltd. and F. Hoffmann–La Roche Ltd. announced today that FDA has accepted the complete response resubmission that Roche made to the U.S. Food and Drug Administration for the Biologics License Application (BLA) for Actemra the humanized anti–human IL–6 (interleukin–6) receptor monoclonal antibody, following the receipt of the Complete Response Letter in September 2008.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09

Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
Forest Laboratories, 10/29/09

See All of Research & Development